BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/30/2021 9:35:11 AM | Browse: 415 | Download: 978
 |
Received |
|
2021-02-01 16:13 |
|
Peer-Review Started |
|
2021-02-01 16:42 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-30 23:51 |
|
Revised |
|
2021-05-10 07:46 |
|
Second Decision |
|
2021-08-04 03:32 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-04 07:00 |
|
Articles in Press |
|
2021-08-04 07:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-10-21 04:54 |
|
Typeset the Manuscript |
|
2021-11-24 02:50 |
|
Publish the Manuscript Online |
|
2021-11-30 09:35 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Opinion Review |
| Article Title |
Regulating monocyte infiltration and differentiation: Provide new therapies for colorectal cancer patients with COVID-19
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ling Bai, Wang Yang, Lei Qian and Jiu-Wei Cui |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the National Key Research and Development Program of New Coronary Pneumonia and Other Infectious Diseases Prevention Basic Research Orientation Project of China |
2020YFA0707704 |
| the Ministry of Science and Technology of the People’s Republic of China |
2016YFC1303804 |
| the Interdisciplinary Research Funding Program of Jilin University |
101832020DJX083 |
| the outstanding Talent Cultivation Program for Doctoral Students in Norman Bethune Health Science Center of Jilin University |
- |
|
| Corresponding Author |
Jiu-Wei Cui, MD, PhD, Chief Doctor, Professor, Cancer Center, The First Hospital of Jilin University, No. 71 Xinmin Street, Changchun 130021, Jilin Province, China. cuijw@jlu.edu.cn |
| Key Words |
COVID-19; SARS-CoV-2; Monocyte; Macrophage; Colorectal cancer |
| Core Tip |
Not only colorectal cancer (CRC) is susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but its infiltrating monocytes are also affected by SARS-CoV-2. Moreover, after infection, due to the promotion of infiltration and differentiation of monocytes, CRC patients are more likely to develop severe coronavirus disease 2019 (COVID-19). In severe COVID-19, due to the activation of NF-κB and CCR5 signaling pathways, the imbalance of macrophage polarization can further cause the aggravation of cytokine release syndrome. |
| Publish Date |
2021-11-30 09:35 |
| Citation |
Bai L, Yang W, Qian L, Cui JW. Regulating monocyte infiltration and differentiation: Provide new therapies for colorectal cancer patients with COVID-19. World J Clin Cases 2021; 9(34): 10392-10399 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i34/10392.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i34.10392 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
